 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 June 1998 | Volume 128 Issue 11 | Pages 885-889
Background: Most studies of the predictors of systemic embolism in patients with mitral stenosis have been retrospective.
Objective: To prospectively study factors associated with systemic embolism in mitral stenosis.
Design: Prospective cohort study.
Setting: University-affiliated medical institution with 3000 beds.
Patients: 534 consecutive patients with a mitral valve area of 2.0 cm (2) or less; 132 patients were in sinus rhythm, and 402 were in atrial fibrillation.
Measurements: Nine clinical and 10 echocardiographic variables were assessed for prediction of systemic embolism over a mean (±SD) follow-up of 36.9 ± 22.5 months. Diagnosis of systemic embolism was based on symptoms and signs (sudden onset of peripheral arterial ischemic or neurologic manifestations without prodromes) and on findings on computed tomography, angiography, and surgery.
Results: For patients in sinus rhythm, age (relative risk [RR], 1.12 [95% CI, 1.04 to 1.21]), the presence of a left atrial thrombus (RR, 37.1 [CI, 2.82 to 487.8]), mitral valve area (RR, 16.9 [CI, 1.53 to 187.0]), and the presence of significant aortic regurgitation (RR, 22.4 [CI, 2.72 to 184.8]) were positively associated with embolism. For patients in atrial fibrillation, previous embolism (RR, 3.11 [CI, 1.66 to 5.85]) was positively associated with embolism; percutaneous balloon mitral commissurotomy (RR, 0.37 [CI, 0.18 to 0.79]) was a negative predictor.
Conclusions: It may be prudent to give anticoagulants not only to patients in atrial fibrillation and patients with previous systemic embolism but also to those showing a left atrial thrombus or significant aortic regurgitation on echocardiography. Early percutaneous balloon mitral commissurotomy may also help prevent systemic embolism in patients with mitral stenosis.
Eligible patients were consecutive adults (age
End Point
The study end point was the occurrence of new systemic embolism during follow-up. The diagnosis of systemic embolism was based on symptoms and signs (sudden onset of peripheral arterial ischemic [for example, sudden flank pain with hematuria, abdominal pain with gastrointestinal bleeding, or leg pain with pulse deficit] or neurologic manifestations without prodromes) and on findings from computed tomography, angiography, and surgery. We did not attempt to detect silent emboli.
Clinical Variables
We assessed nine clinical variables (Table 1): age at enrollment; sex; presence or absence of previous systemic embolism, atrial fibrillation, hypertension, and New York Heart Association class III or IV congestive heart failure; and therapy with anticoagulants, percutaneous balloon mitral commissurotomy, or valvular surgery. Patients were regularly followed at outpatient clinics. ARTICLE
Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study
Systemic, especially cerebral, embolism is one of the major causes of illness and death in patients with mitral stenosis [1-5]. Identification of risk factors for embolism may improve the strategies for preventing this event. However, most large studies addressing risk predictors have been retrospective [1, 2, 6-9]. We sought to reappraise this issue in a large, prospective study.
Methods
Top
Methods
Results
Discussion
Author & Article Info
References
Patients
15 years) with mitral stenosis (mitral valve area 
2 cm2 according to echocardiographic planimetry) who presented to a university-affiliated medical institution from April 1987 to December 1994. We excluded patients with infective endocarditis and those who were in critical condition because of systemic embolism and died during hospitalization.
|
Echocardiographic Method and Variables
Standard transthoracic echocardiography was done at enrollment in all patients by using a Hewlett-Packard 7340, Sonos 1000, or Sonos 1500 echocardiographic system (Hewlett-Packard, Palo Alto, California) interfaced with both 2.5-MHz and 5.0-MHz transducers. Biplane or omniplane transesophageal echocardiography using a 5.0-MHz transducer was also performed in a subgroup of consecutive patients who entered the study from September 1991 to October 1992. Ten echocardiographic variables were examined (Table 1). Mitral valve area was measured by planimetry from two-dimensional echocardiography. When two-dimensional echocardiography of the mitral orifice yielded unsatisfactory results, we used the pressure half-time (T1/2) method (mitral valve area [cm2] = 220/T1/2 ms) [10-12]. We did not use the pressure half-time method when the mitral orifice could be clearly defined by two-dimensional echocardiography because pressure half-time is influenced by many factors other than mitral valve area [13, 14]. Other echocardiographic variables were left atrial diameter at end systole; presence or absence of a left atrial thrombus [15] or left atrial smoky echoes on transthoracic or transesophageal echocardiography [16-18]; presence or absence of impaired left ventricular systolic performance; and presence or absence of significant (moderate or severe) aortic stenosis, aortic regurgitation, mitral regurgitation, tricuspid regurgitation, or pulmonic regurgitation.
The degrees of these valvular lesions were semiquantified by using a continuity equation (for aortic stenosis) or color Doppler imaging (for various regurgitations), as described elsewhere [19, 20]. Briefly, significant aortic stenosis refers to an aortic valve area of 1.2 cm2 or less determined by the continuity Equation method RF 19*; significant mitral or tricuspid regurgitation refers to a ratio of regurgitant jet area to left or right atrial area of 20% or more; and significant aortic or pulmonic regurgitation refers to a ratio of jet width to ventricular outflow tract diameter of 25% or more [20]. Left atrial diameter at end systole was measured from an M-mode echocardiogram recorded in parasternal long-axis view. The measurement was made according to the recommendations of the American Society of Echocardiography [21]. To detect left atrial smoky echoes, we used a 5-MHz transducer during transthoracic and transesophageal echocardiography because a 5-MHz transducer is more sensitive than a 2.5-MHz transducer [16].
We chose the term smoky echoes instead of spontaneous echocardiographic contrast (a term frequently used in other studies [6, 7]) because some patients with severe tricuspid regurgitation or right heart failure had bright moving spots (originating from microbubbles) in the venae cavae or hepatic veins that were identical to those seen during contrast echocardiography. Thus, we reserve spontaneous echocardiographic contrast for that echocardiographic pattern and use smoky echoes for the finer, lighter whorling echoes (originating from aggregated erythrocytes) [16-18] that appeared in the left atrium in patients with severe mitral stenosis.
Statistical Analysis
For each clinical and echocardiographic measure, the log-rank statistic was used to determine whether the overall pattern of the time to development of systemic embolism (embolism-free time) varied among levels of the measure. Mean embolism-free time was estimated by using a nonparametric method that considers censoring [22]. Cox regression was used to examine the significance of the clinical and echocardiographic variables in predicting embolism-free time for patients in sinus rhythm and patients in atrial fibrillation. All analyses were performed by using BMDP Dynamic Release 7.0 [23].
Results
|
|---|
|
TopMethodsResultsDiscussionAuthor & Article InfoReferences |
|---|
When Cox regression was performed, significant interaction was found between atrial fibrillation and age, percutaneous balloon mitral commissurotomy, mitral valve area, previous systemic embolism, left atrial thrombus, and anticoagulation. In other words, the significance of these variables depended to some extent on whether the patient was in atrial fibrillation or sinus rhythm. We therefore performed subgroup analyses.
Subgroup Analyses
Of the 132 patients in sinus rhythm, 12 (9.1%) developed systemic embolism during follow-up. Age (P < 0.001), percutaneous balloon mitral commissurotomy (P = 0.02), and mitral valve area (P = 0.02) were significant predictors in the log-rank analysis (Table 2). Results of the Cox regression showed that age (relative risk [RR], 1.12 [95% CI, 1.04 to 1.21]), left atrial thrombus (RR, 37.1 [CI, 2.82 to 487.8]), mitral valve area (RR, 16.9 [CI, 1.53 to 187.0]), and significant aortic regurgitation (RR, 22.4 [CI, 2.72 to 184.8]) were significant predictors of new systemic embolism (Table 3). No interactions were found among these variables. However, mitral valve area became a nonsignificant predictor (P = 0.12) when patients with percutaneous balloon mitral commissurotomy were excluded from the analysis.
|
|
Of the 402 patients in atrial fibrillation, 48 (11.9%) developed systemic embolism. Age (P = 0.01), previous embolism (P = 0.001), and percutaneous balloon mitral commissurotomy (P = 0.003) were significant predictors in the univariate analysis (Table 2). In the multivariate analysis, however, only previous embolism (RR, 3.11 [CI, 1.66 to 5.85]) and percutaneous balloon mitral commissurotomy (RR, 0.37 [CI, 0.18 to 0.79]) remained significant predictors of embolism-free time (Table 3). Again, no interactions were found between these two variables.
A subgroup analysis of the 164 patients who underwent baseline transesophageal echocardiography revealed no other significant predictors.
Discussion
|
|---|
|
TopMethodsResultsDiscussionAuthor & Article InfoReferences |
|---|
Our prospective study revealed that for patients in sinus rhythm, embolization was related to age, mitral valve area, the presence of a left atrial thrombus, and significant aortic regurgitation. For patients in atrial fibrillation, the significant factors were previous embolism and percutaneous balloon mitral commissurotomy (Table 3). Other retrospective studies have shown that atrial fibrillation [1, 2, 8], age [1, 2, 8], and previous embolism [3] correlate with increased incidence of systemic embolism in patients with mitral stenosis and that age is closely related to the prevalence of atrial fibrillation [24] and to a history of embolization [1, 2, 8]. Several studies have shown that anticoagulation reduces the incidence of systemic embolism in patients with mitral stenosis and atrial fibrillation [25-27]. To the best of our knowledge, however, our study is the first to show that the presence of a left atrial thrombus and significant aortic regurgitation are positive predictors and that percutaneous balloon mitral commissurotomy seems to be a negative predictor.
Left Atrial Thrombus and Systemic Embolism in Patients with Mitral Stenosis Who Are in Sinus Rhythm
Dislodgement of a left atrial thrombus in patients with mitral stenosis has been thought to lead to systemic embolism. Although a correlation between left atrial thrombus and systemic thrombus would be expected, previous studies have not confirmed such a correlation. We found that the presence of a left atrial thrombus was a positive predictor (RR, 37.1 [CI, 2.82 to 487.8]) for patients in sinus rhythm (Table 3). It is generally accepted that anticoagulants should be given to patients with mitral stenosis who are in atrial fibrillation [25-27], but the appropriate use of these agents in patients with mitral stenosis who are in sinus rhythm has been uncertain. Our findings suggest that anticoagulation would be appropriate at least for patients with a left atrial thrombus shown by two-dimensional echocardiography.
Aortic Regurgitation and Systemic Embolism in Patients with Mitral Stenosis Who Are in Sinus Rhythm
We found that the presence of significant (moderate or severe) aortic regurgitation was a positive predictor (RR, 22.4 [CI, 2.72 to 184.8]) of systemic embolism in patients with mitral stenosis who are in sinus rhythm. One possible explanation is that because significant aortic regurgitation tends to increase left ventricular diastolic pressure, the diastolic pressure gradient between the left atrium and the left ventricle would be decreased. This sets the stages for reduction of transmitral blood flow, aggravation of left atrial blood stasis, predisposition to left atrial thrombus formation, and systemic embolism.
Mitral Valve Area and Systemic Embolism in Patients with Mitral Stenosis Who Are in Sinus Rhythm
One would expect that the smaller the mitral valve area, the higher the incidence of systemic embolism. A first glance at Table 3 may lead one to think that our study showed the contrary-that patients with a larger, rather than smaller, mitral valve area seemed to have a high risk for systemic embolism. However, a more careful examination of the data shows that the significance of mitral valve area in patients in sinus rhythm could be a false alarm. Patients with a small mitral valve area were more likely to have had percutaneous balloon mitral commissurotomy. When patients who underwent percutaneous balloon mitral commissurotomy were excluded, mitral valve area became a nonsignificant predictor (P = 0.12). Another implication of this finding could be that the prevention of systemic embolism in patients with mitral stenosis may need to be forestalled at the earliest opportunity as long as the mitral valve area is 2 cm2 or less. Further studies are needed to clarify this issue.
Percutaneous Balloon Mitral Commissurotomy and Systemic Embolism in Patients with Mitral Stenosis Who Are in Atrial Fibrillation
Percutaneous balloon mitral commissurotomy has become one of the standard, and often first-line, treatments for patients with mitral stenosis [28-32]. It can substantially alleviate symptoms [31]. In our study, we were encouraged to find that percutaneous balloon mitral commissurotomy was a negative predictor of systemic embolism in patients with mitral stenosis who were in atrial fibrillation (Table 3). We speculate that in some patients, the presence of an interarterial shunt might lead to pulmonary embolism instead of systemic embolism when a left atrial thrombus becomes dislodged. Amelioration of regional left atrial hypercoagulability by balloon mitral commissurotomy may also play a role [33]. The identification of percutaneous balloon mitral commissurotomy as an independent negative predictor of systemic embolism favors the early use of this procedure in patients with mitral stenosis who are in atrial fibrillation. Because the procedure seemed to be an independent negative predictor, it would help patients regardless of their anticoagulation status. Furthermore, earlier intervention may also be beneficial in patients in sinus rhythm to prevent the development of atrial fibrillation and systemic embolism.
Left Atrial Smoky Echoes and Systemic Embolism in Patients with Mitral Stenosis
Previous retrospective studies have reported that the presence of left atrial smoky echoes by transesophageal echocardiography might favor the occurrence of systemic embolism in patients with mitral stenosis [6, 7]. Our prospective study of a subgroup of 164 patients who underwent baseline transesophageal echocardiography did not confirm this finding. Nevertheless, we found that the significance of previous embolism was just above the 0.05 limit (P = 0.056) when left atrial smoky echoes were present. This implies that left atrial smoky echoes might confound or interact with other variables. However, only 11 patients in this subgroup had embolism; larger studies are needed to clarify the issue.
Clinical Implications
We discovered important predictors of systemic embolism in patients with mitral stenosis; these findings suggest that anticoagulation may be prudent not only in patients in atrial fibrillation and patients with a previous systemic embolism but also in patients showing significant aortic regurgitation or left atrial thrombi on echocardiography. Therefore, echocardiography should be carefully performed to look for any evidence of left atrial thrombus or significant aortic regurgitation in patients who are in sinus rhythm and have no history of systemic embolism. Our study also suggests that early percutaneous balloon mitral commissurotomy may be another effective measure (regardless of anticoagulation status) to help prevent systemic embolism in patients with mitral stenosis.
From Chang Gung Memorial Hospital and Chang Gung University, Taipei, Taiwan, Republic of China; and Deaking University, Burwood, Victoria, Australia.
Dr. Lo: School of Public Health Faculty of Health and Behavioral Science, Deakin University, 221 Burwood Highway, Burwood, Victoria 3125, Australia.
Author and Article Information
|
|---|
|
TopMethodsResultsDiscussionAuthor & Article InfoReferences |
|---|
References
|
|---|
|
TopMethodsResultsDiscussionAuthor & Article InfoReferences |
|---|
1. Casella L, Abelmann WH, Ellis LB. Patients with mitral stenosis and systemic emboli: hemodynamic and clinical observations. Arch Intern Med. 1964; 114:773-81.
2. Coulshed N, Epstein EJ, McKendrick CS, Galloway RW, Walker E. Systemic embolism in mitral valve disease. Br Heart J. 1970; 32:26-34.
3. Easton JD, Sherman DG. Management of cerebral embolism of cardiac origin. Stroke. 1980; 11:433-42.
4. Cardiogenic brain embolism. Cerebral Embolism Task Force. Arch Neurol. 1986; 43:71-84.
5. Horstkotte D, Niehues R, Strauer BE. Pathomorphological aspects, aetiology and natural history of acquired mitral valve stenosis. Eur Heart J. 1991; 12(Suppl B):55-60.
6. Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 1991; 18:398-404.
7. Daniel WG, Nellessen U, Schroder E, Nonnast-Daniel B, Bednerski P, Nikutta P, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol. 1988; 11:1204-11.
8. Chiang CW, Lo SK, Kuo CT, Cheng NJ, Hsu TS. Nonivasive predictors of systemic embolism in mitral stenosis. An echocardiographic and clinical study of 500 patients. Chest. 1994; 106:396-9.
9. Hwang JJ, Kuan P, Lin SC, Chen WJ, Lei MH, Ko YL, et al. Reappraisal by transesophageal echocardiography of the significance of left atrial thrombi in the prediction of systemic arterial embolization in rheumatic mitral valve disease. Am J Cardiol. 1992; 70:769-73.
10. Hatle L, Angelsen B, Tromsdal A. Noninvasive assessment of atrioventricular pressure half-time by Doppler ultrasound. Circulation. 1979; 60:1096-104.
11. Smith MD, Handshoe R, Handshoe S, Kwan OL, DeMaria AN. Comparative accuracy of two-dimensional echocardiography and Doppler pressure half-time methods in assessing severity of mitral stenosis in patients with and without prior commissurotomy. Circulation. 1986; 73:100-7.
12. Thomas JD, Weyman AE. Doppler mitral pressure half-time: a clinical tool in search of theoretical justification. J Am Coll Cardiol. 1987; 10:923-9.
13. Loyd D, Ask P, Eng D, Wranne B. Pressure half-time does not always predict mitral valve area correctly. J Am Soc Echocardiogr. 1988; 1:313-21.
14. Chiang CW, Cherng WG, Chang FJ, Lin FC, Fang BR, Kao CT, et al. Effect of heart rate on pressure half-time in patients with mitral stenosis. Chang Keng I Hsueh. 1992; 15:72-7.
15. Chiang CW, Pang SC, Lin FC, Fang BR, Kuo CT, Lee YS. Diagnostic accuracy of two-dimensional echocardiography for detection of left atrial thrombus in patients with mitral stenosis. J Ultrasound Med. 1987; 6:525-9.
16. Iliceto S, Antonelli G, Sorino M, Blasco G, Rizzon P. Dynamic intracavitary left atrial echoes in mitral stenosis. Am J Cardiol. 1985; 55:603-6.
17. Chiang CW, Lin FC, Fang BR, Kuo CT, Lee YS, Chang CH. "Sand-drift" echoes and thrombus formation in the left atrium. Am Heart J. 1988; 115:908-11.
18. Sigel B, Coelho JC, Spigos DG, Flanigan DP, Schuler JJ, Kasprisin DO, et al. Ultrasonography of blood during stasis and coagulation. Invest Radiol. 1981; 16:71-6.
19. Richards KL, Cannon SR, Miller JF, Crawford MH. Calculation of aortic valve area by Doppler echocardiography: a direct application of the continuity equation. Circulation. 1986; 73:964-9.
20. Cooper JW, Nanda NC, Philpot EF, Fan P. Evaluation of valvular regurgitation by color Doppler. J Am Soc Echocardiogr. 1989; 2:56-66.
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: result of a survey of echocardiographic measurements. Circulation. 1978; 58:1072-83.
22. Selvin S. Practical Biostatistical Methods. Belmont, CA: Duxbury Pr; 1995:124-5, 425-30.
23. Dixon WJ, ed. BMDP Statistical Software Manual. Los Angeles: Univ of California Pr; 1990.
24. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271:840-4.
25. Roy D, Marchand E, Gagne P, Chabot M, Cartier R. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation. Am Heart J. 1986; 112:1039-43.
26. Petersen P, Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke. 1986; 17:622-6.
27. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989; 1:175-9.
28. Inoue K, Owaki T, Nakamura T, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984; 87:394-402.
29. Vahanian A, Michel PL, Cormier B, Vitoux B, Michel X, Slama M, et al. Results of percutaneous mitral commissurotomy in 200 patients. Am J Cardiol. 1989; 63:847-52.
30. Ruiz CE, Allen JW, Lau FY. Percutaneous double balloon valvotomy for severe rheumatic mitral stenosis. Am J Cardiol. 1990; 65:473-7.
31. Hung JS, Chern MS, Wu JJ, Fu M, Yeh KH, Wu YC, et al. Short- and long-term results of catheter balloon percutaneous transvenous mitral commissurotomy. Am J Cardiol. 1991; 67:854-62.
32. Chiang CW, Hsu LA, Chu PH, Ko YS, Ko YL, Cheng NJ, et al. On-line multiplane transesophageal echocardiography for balloon mitral commissurotomy. Am J Cardiol. 1998; 81:515-8.
33. Peverill RE, Harper RW, Harris G, Gan TE, Smolich JJ. Amelioration of regional left atrial hypercoagulability by balloon mitral valvuloplasty in patients with mitral stenosis. Circulation. 1995; 92(Suppl 1):1-21.
This article has been cited by other articles:
|
|
 |
|
  2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]
|
|
|
|
 |
|
 D. N. Salem, P. T. O'Gara, C. Madias, and S. G. Pauker Valvular and Structural Heart Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 593S - 629S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Mittnacht, M. Fanshawe, and S. Konstadt Anesthetic Considerations in the Patient With Valvular Heart Disease Undergoing Noncardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2008; 12(1): 33 - 59. [Abstract] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur. Heart J., January 26, 2007; (2007) ehl428v1. [Full Text] [PDF]
|
|
|
|
 |
|
 D J H McCabe and R D Rakhit Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 14 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]
|
|
|
|
 |
|
 C L Hu, H Jiang, Q Z Tang, Q H Zhang, J B Chen, C X Huang, and G S Li Comparison of rate control and rhythm control in patients with atrial fibrillation after percutaneous mitral balloon valvotomy: a randomised controlled study Heart, August 1, 2006; 92(8): 1096 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Nakajima, J. Kobayashi, K. Bando, Y. Yasumura, S. Nakatani, K. Kimura, K. Niwaya, O. Tagusari, and S. Kitamura Consequence of atrial fibrillation and the risk of embolism after percutaneous mitral commissurotomy: The necessity of the maze procedure Ann. Thorac. Surg., September 1, 2004; 78(3): 800 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 457S - 482S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Chen, C.-J. Wu, H.-W. Chang, H.-K. Yip, Y.-H. Chen, C.-I Cheng, and H.-T. Chai Mechanism of Reducing Platelet Activity by Percutaneous Transluminal Mitral Valvuloplasty in Patients With Rheumatic Mitral Stenosis Chest, May 1, 2004; 125(5): 1629 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vahanian and I. F. Palacios Percutaneous Approaches to Valvular Disease Circulation, April 6, 2004; 109(13): 1572 - 1579. [Full Text] [PDF]
|
|
|
|
|
|
B. Iung, C. Gohlke-Barwolf, P. Tornos, C. Tribouilloy, R. Hall, E. Butchart, and A. Vahanian Recommendations on the management of the asymptomatic patient with valvular heart disease Eur. Heart J., August 2, 2002; 23(16): 1253 - 1266. [PDF]
|
|
|
|
|
|
Y. Agmon, B. K. Khandheria, F. Gentile, and J. B. Seward Clinical and Echocardiographic Characteristics of Patients With Left Atrial Thrombus and Sinus Rhythm: Experience in 20 643 Consecutive Transesophageal Echocardiographic Examinations Circulation, January 1, 2002; 105(1): 27 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Salem, D. Hartnett Daudelin, H. J. Levine, S. G. Pauker, M. H. Eckman, and J. Riff Antithrombotic Therapy in Valvular Heart Disease Chest, January 1, 2001; 119(1_suppl): 207S - 219S. [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Petty, B. K. Khandheria, J. P. Whisnant, J. D. Sicks, W. M. O'Fallon, and D. O. Wiebers Predictors of Cerebrovascular Events and Death Among Patients With Valvular Heart Disease : A Population-Based Study Stroke, November 1, 2000; 31(11): 2628 - 2635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Predicting Systemic Embolism in Mitral Stenosis Journal Watch Cardiology, June 19, 1998; 1998(619): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Emboli and Mitral Stenosis: A Risk Even in Sinus Rhythm? Journal Watch (General), June 12, 1998; 1998(612): 1 - 1. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
